These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 18295343

  • 21. Long-acting risperidone in young adults with early schizophrenia or schizoaffective illness.
    Lasser RA, Bossie CA, Zhu Y, Locklear JC, Kane JM.
    Ann Clin Psychiatry; 2007; 19(2):65-71. PubMed ID: 17612845
    [Abstract] [Full Text] [Related]

  • 22. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
    Paleacu D, Barak Y, Mirecky I, Mazeh D.
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
    [Abstract] [Full Text] [Related]

  • 23. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
    Cesková E, Svestka J.
    Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder.
    Lasser RA, Bossie CA, Zhu Y, Gharabawi G, Eerdekens M, Davidson M.
    Int J Geriatr Psychiatry; 2004 Sep; 19(9):898-905. PubMed ID: 15352149
    [Abstract] [Full Text] [Related]

  • 25. Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms.
    Riedel M, Spellmann I, Strassnig M, Douhet A, Dehning S, Opgen-Rhein M, Valdevit R, Engel RR, Kleindienst N, Müller N, Möller HJ.
    Eur Arch Psychiatry Clin Neurosci; 2007 Sep; 257(6):360-70. PubMed ID: 17629731
    [Abstract] [Full Text] [Related]

  • 26. A trial of quetiapine compared with risperidone in the treatment of first onset psychosis among 15- to 18-year-old adolescents.
    Swadi HS, Craig BJ, Pirwani NZ, Black VC, Buchan JC, Bobier CM.
    Int Clin Psychopharmacol; 2010 Jan; 25(1):1-6. PubMed ID: 19809337
    [Abstract] [Full Text] [Related]

  • 27. Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidone.
    Westheide J, Cvetanovska G, Albrecht C, Bliesener N, Cooper-Mahkorn D, Creutz C, Hornung WP, Klingmüller D, Lemke MR, Maier W, Schubert M, Sträter B, Kühn KU.
    J Sex Med; 2008 Dec; 5(12):2816-26. PubMed ID: 18466271
    [Abstract] [Full Text] [Related]

  • 28. Long-acting risperidone in stable patients with schizoaffective disorder.
    Mohl A, Westlye K, Opjordsmoen S, Lex A, Schreiner A, Benoit M, Bräunig P, Medori R.
    J Psychopharmacol; 2005 Sep; 19(5 Suppl):22-31. PubMed ID: 16144783
    [Abstract] [Full Text] [Related]

  • 29. Switching to quetiapine in patients with acute mania who were intolerant to risperidone.
    Pae CU, Lee KU, Kim JJ, Lee CU, Bahk WM, Lee SJ, Lee C, Paik IH.
    Hum Psychopharmacol; 2004 Jan; 19(1):47-51. PubMed ID: 14716712
    [Abstract] [Full Text] [Related]

  • 30. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
    DelBello MP, Chang K, Welge JA, Adler CM, Rana M, Howe M, Bryan H, Vogel D, Sampang S, Delgado SV, Sorter M, Strakowski SM.
    Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
    [Abstract] [Full Text] [Related]

  • 31. Clozapine alone versus clozapine and risperidone with refractory schizophrenia.
    Honer WG, Thornton AE, Chen EY, Chan RC, Wong JO, Bergmann A, Falkai P, Pomarol-Clotet E, McKenna PJ, Stip E, Williams R, MacEwan GW, Wasan K, Procyshyn R, Clozapine and Risperidone Enhancement (CARE) Study Group.
    N Engl J Med; 2006 Feb 02; 354(5):472-82. PubMed ID: 16452559
    [Abstract] [Full Text] [Related]

  • 32. A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial.
    Sacchetti E, Valsecchi P, Parrinello G, QUERISOLA Group.
    Schizophr Res; 2008 Jan 02; 98(1-3):55-65. PubMed ID: 17933497
    [Abstract] [Full Text] [Related]

  • 33. An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms.
    Timdahl K, Carlsson A, Stening G.
    Hum Psychopharmacol; 2007 Jul 02; 22(5):315-25. PubMed ID: 17542047
    [Abstract] [Full Text] [Related]

  • 34. Comparison of quetiapine and risperidone in the treatment of schizophrenia: A randomized, double-blind, flexible-dose, 8-week study.
    Zhong KX, Sweitzer DE, Hamer RM, Lieberman JA.
    J Clin Psychiatry; 2006 Jul 02; 67(7):1093-103. PubMed ID: 16889453
    [Abstract] [Full Text] [Related]

  • 35. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
    Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, Lee E, Greenspan A.
    Int J Geriatr Psychiatry; 2005 Dec 02; 20(12):1153-7. PubMed ID: 16315159
    [Abstract] [Full Text] [Related]

  • 36. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
    Buckley PF, Paulsson B, Brecher M.
    J Affect Disord; 2007 Dec 02; 100 Suppl 1():S33-43. PubMed ID: 17376537
    [Abstract] [Full Text] [Related]

  • 37. A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization.
    Potkin SG, Gharabawi GM, Greenspan AJ, Mahmoud R, Kosik-Gonzalez C, Rupnow MF, Bossie CA, Davidson M, Burtea V, Zhu Y, Trivedi JK.
    Schizophr Res; 2006 Jul 02; 85(1-3):254-65. PubMed ID: 16797162
    [Abstract] [Full Text] [Related]

  • 38. A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea.
    Lee NY, Kim SH, Cho SJ, Chung YC, Jung IK, Kim CY, Kim DH, Lee DG, Lee YH, Lim WJ, Na YS, Shin SE, Woo JM, Yoon JS, Yoon BH, Ahn YM, Kim YS.
    Int Clin Psychopharmacol; 2014 Sep 02; 29(5):279-87. PubMed ID: 24583566
    [Abstract] [Full Text] [Related]

  • 39. Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable.
    Parellada E, Andrezina R, Milanova V, Glue P, Masiak M, Turner MS, Medori R, Gaebel W.
    J Psychopharmacol; 2005 Sep 02; 19(5 Suppl):5-14. PubMed ID: 16144781
    [Abstract] [Full Text] [Related]

  • 40. Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.
    Rossi A, Bagalà A, Del Curatolo V, Scapati F, Bernareggi MM, Giustra MG, Risperidone Long-Acting Trial Investigators (R-LAI).
    Hum Psychopharmacol; 2009 Oct 02; 24(7):574-83. PubMed ID: 19790173
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.